BioCentury | Aug 29, 2018
Distillery Therapeutics


...the product in Phase II testing for colorectal cancer. Advaxis and Bristol-Myers Squibb Co. have ADXS-DUAL...
BioCentury | May 31, 2017
Company News

Advaxis, BMS partner to evaluate ADXS-DUAL plus Opdivo in cervical cancer

...Advaxis Inc. (NASDAQ:ADXS) will sponsor a clinical trial evaluating its ADXS-DUAL in combination with PD-1 inhibitor...
...Opdivo nivolumab to treat metastatic cervical cancer. The trial is slated to start this year. ADXS-DUAL...
Items per page:
1 - 2 of 2